ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 682817 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 682817; 2) Community: the network communities that were significantly associated with the response to NSC 682817; 3) Molecule: the relationships between components within communities and NSC 682817; 4) MDR: the compounds that were significantly associated with the NSC 682817.

NSC Compound Enrichment Correlation
NSC 658450 2-Acetamido-6-methyl-8-hydroxy-1,4-naphthaquinone 0.0291420747327559 -0.31752903
NSC 667876 Null 0.0291420747327559 -0.26480463
NSC 672141 Null 0.0291420747327559 -0.31414824
NSC 674964 Spiro[s-indacene-2(1H),2'-[2H]indene]-8-carboxylic acid, 3,5,6,7,1',3'-hexahydro-3'-oxo- 0.0291420747327559 -0.46396241
NSC 675772 Glutamic acid, N-[4-[[6-(trifluoromethyl)-2-quinoxalinyl] amino]benzoyl]-, diethyl ester 0.0291420747327559 0.72230182
NSC 67774 Null 0.0291420747327559 0.55505453
NSC 678383 Benzoic acid, 2-[(4,6-dimethyl-1-oxo-2-indanylidene) methyl]-5-methyl-, methyl ester 0.0291420747327559 0.61118856
NSC 680935 2H-Furo[3',2':3,4]benzopyrano[6,7-b]pyridine- 2,6,11-trione, 2,3-dihydro-5,5,8-trimethyl- 0.0291420747327559 -0.29928894
NSC 321491 Null 0.0321614375606954 0.3147913
NSC 328410 Camptothecin Derivative 0.0321614375606954 0.29728247
Total:65  Current:40    [First] [Prev] [Next] [Last]